Logo

Alvalux Medical SA

Société
1 abonné

Onglets principaux

À propos de votre organisation / profil

A leading Belgian therapeutic wearables company in global expansion mode

  • First product CicaLux – researched, developed and launched.
  • CE Mark and US FDA registrations achieved.
  • First €3M in contract sales signed in 10 countries.
  • Earned 4 product awards in France, UK, and USA.
  • Complementary product pipeline with IP,  >€60 billion market size.
  • Teamed with Dupont-Dow and UCL-Université catholique de Louvain.
  • Strong and efficient USA-EU experienced management team. 
  • USA subsidiary established and ready for growth.

Seeking funds to fuel sales growth in the USA - our largest market. 

€1.5 - 2.5M lead investor sought to match Noshaq and SRIW in our 3-5m Series A round.

Please visit www.alvalux.com and www.cicalux.com for more info and videos.

 

 

 

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Cette organisation ne comporte pas d'utilisateur pour le moment.